The University of Warwick Library - WebBridge
Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial
Davies,
Melanie J..
Diabetes, Obesity and Metabolism.
v.
21.
no.
8.
2019-08.
p.
1967 -
1972...
issn:
1462-8902
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.